Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2476374512;74513;74514 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
N2AB2312269589;69590;69591 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
N2A2219566808;66809;66810 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
N2B1569847317;47318;47319 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
Novex-11582347692;47693;47694 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
Novex-21589047893;47894;47895 chr2:178571845;178571844;178571843chr2:179436572;179436571;179436570
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAT
  • RefSeq wild type template codon: TTA
  • Domain: Ig-133
  • Domain position: 48
  • Structural Position: 122
  • Q(SASA): 0.5431
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/K rs749832389 0.024 0.067 N 0.314 0.083 0.104622674875 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 5.57E-05 None 0 None 0 0 0
N/K rs749832389 0.024 0.067 N 0.314 0.083 0.104622674875 gnomAD-4.0.0 1.59171E-06 None None None None N None 0 0 None 0 2.77408E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.4478 ambiguous 0.4018 ambiguous -0.659 Destabilizing 0.938 D 0.555 neutral None None None None N
N/C 0.3849 ambiguous 0.3454 ambiguous -0.035 Destabilizing 1.0 D 0.769 deleterious None None None None N
N/D 0.3663 ambiguous 0.372 ambiguous -1.084 Destabilizing 0.958 D 0.441 neutral N 0.495278343 None None N
N/E 0.6862 likely_pathogenic 0.6752 pathogenic -1.042 Destabilizing 0.938 D 0.464 neutral None None None None N
N/F 0.5293 ambiguous 0.5109 ambiguous -0.78 Destabilizing 1.0 D 0.779 deleterious None None None None N
N/G 0.5488 ambiguous 0.508 ambiguous -0.921 Destabilizing 0.968 D 0.411 neutral None None None None N
N/H 0.1291 likely_benign 0.1271 benign -0.85 Destabilizing 0.994 D 0.666 neutral D 0.527403008 None None N
N/I 0.2732 likely_benign 0.2548 benign -0.024 Destabilizing 0.994 D 0.801 deleterious D 0.536465209 None None N
N/K 0.5042 ambiguous 0.5094 ambiguous -0.153 Destabilizing 0.067 N 0.314 neutral N 0.503080567 None None N
N/L 0.3038 likely_benign 0.2859 benign -0.024 Destabilizing 0.991 D 0.71 prob.delet. None None None None N
N/M 0.3939 ambiguous 0.3667 ambiguous 0.582 Stabilizing 1.0 D 0.733 prob.delet. None None None None N
N/P 0.9576 likely_pathogenic 0.9558 pathogenic -0.207 Destabilizing 0.995 D 0.752 deleterious None None None None N
N/Q 0.5099 ambiguous 0.4941 ambiguous -1.009 Destabilizing 0.991 D 0.669 neutral None None None None N
N/R 0.4973 ambiguous 0.4888 ambiguous -0.002 Destabilizing 0.982 D 0.569 neutral None None None None N
N/S 0.1295 likely_benign 0.1189 benign -0.701 Destabilizing 0.958 D 0.385 neutral N 0.497656104 None None N
N/T 0.1912 likely_benign 0.1673 benign -0.5 Destabilizing 0.958 D 0.494 neutral N 0.472299087 None None N
N/V 0.3056 likely_benign 0.2724 benign -0.207 Destabilizing 0.991 D 0.783 deleterious None None None None N
N/W 0.8331 likely_pathogenic 0.8273 pathogenic -0.602 Destabilizing 1.0 D 0.784 deleterious None None None None N
N/Y 0.2277 likely_benign 0.2161 benign -0.329 Destabilizing 0.998 D 0.769 deleterious N 0.508155585 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.